港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

27.450

+1.1504.37%

成交量：101.82万

成交额：2,728.23万

市值：108.95亿

市盈率：-34.83

高：28.500

开：26.400

低：25.500

收：26.300

数据加载中...

总览公司新闻公告

药捷安康-B上市一周累涨逾100%！核心产品替恩戈替尼获FDA快速通道认证

老虎资讯综合

【港股异动 | 药捷安康-B(02617.HK)再涨超5% 总市值超110亿美元恩戈替尼获美国FDA快速通道认证】智通

【港股异动 | 药捷安康-B(02617.HK)尾盘拉升近5% 较招股价实现翻倍替恩戈替尼获FDA快速通道认证】智通财

【港股异动 | 药捷安康-B(02617.HK)上市次日再涨6% 核心产品替恩戈替尼获FDA快速通道认证】智通财经APP

药捷安康-B续涨7%，总市值逼近100亿港元；该股昨日上市首日飙涨近79%

老虎资讯综合

【药捷安康-B(02617.HK)：替恩戈替尼(TT-00420)被授予治疗MCRPC快速通道认证】智通财经APP讯，药

【湾区早参】深圳二手房在售量超过72000套；广州发布智能网联汽车发展计划

药捷安康-B(02617.HK)：替恩戈替尼(TT-00420)被授予治疗MCRPC快速通道认证

中信证券保荐生物科技领先公司药捷安康成功登陆港交所

中信证券发布

【港股异动 | 康方生物(09926.HK)盘中涨近6% 药捷安康上市首日暴涨82% 康方生物为基石投资者之一】智通财经

药捷安康登陆港交所为今年南京江北新区首家上市企业

港股午评：低开高走！三大指数盘中均转涨，半导体股拉升，港口及海运股大涨

药捷安康-B上市首日盘中涨幅扩大至80%，中签一手赚超5000港元

老虎资讯综合

“60后”博士四闯港交所，小分子Biotech开局大涨70%

动脉新医药

异动解读 | 药捷安康-B上市首日大涨63%，创新药研发引爆投资热情

异动解读 | 药捷安康-B上市首日大涨63%，IPO超额认购3420倍

港股早评：三大指数低开科技金融走低油气股、海运股大涨，三花智控首日上市低开7%

新股首日｜药捷安康-B飙涨超64%，佰泽医疗涨超24%，三花智控破发开跌7%

老虎资讯综合

新股定价 | 药捷安康-B每股定价13.15港元，公开发售超购近3419倍，一手中签率0.8%

老虎资讯综合

《新股》药捷安康(02617.HK)公开发售超购近3,419倍一手中签仅0.8%

阿斯达克财经

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02617/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":27.45,"timestamp":1751007607527,"preClose":26.3,"halted":0,"volume":1018200,"delay":0,"floatShares":301666673,"shares":396897633,"eps":-0.788165265291384,"marketStatus":"交易中","change":1.15,"latestTime":"06-27 15:00:11","open":26.4,"high":28.5,"low":25.5,"amount":27282275,"amplitude":0.114068,"askPrice":27.6,"askSize":1000,"bidPrice":27.45,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.788165265291384,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1751011800000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":26.3,"openAndCloseTimeList":[[1750987800000,1750996800000],[1751000400000,1751011200000]],"volumeRatio":0.360437,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-24.05%","roe":"-41.98%","lyrEps":-0.788165,"volumeRatio":0.360437,"shares":396897633,"dividePrice":0,"high":28.5,"amplitude":0.114068,"preClose":26.3,"low":25.5,"week52Low":20.2,"pbRate":"18.95","week52High":28.5,"institutionHeld":0,"latestPrice":27.45,"committee":0.333333,"eps":-0.788165265291384,"divideRate":0,"volume":1018200,"delay":0,"ttmEps":-0.788165265291384,"open":26.4,"prevYearClose":13.15,"prevWeekClose":13.15,"prevMonthClose":13.15,"prevQuarterClose":13.15,"fiveDayClose":13.15,"twentyDayClose":13.15,"sixtyDayClose":13.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178074725","title":"药捷安康-B上市一周累涨逾100%！核心产品替恩戈替尼获FDA快速通道认证","url":"https://stock-news.laohu8.com/highlight/detail?id=1178074725","media":"老虎资讯综合","labels":["productRelease","policyRegulatory"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1178074725?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 14:05","pubTimestamp":1751004359,"startTime":"0","endTime":"0","summary":"6月27日，港股次新股$药捷安康-B$午后拉升，上市一周累涨逾100%！药捷安康近日宣布，其自主研发的多靶点激酶抑制剂替恩戈替尼，已获$美国食品$药物管理局授予治疗转移性去势抵抗性前列腺癌的快速通道认证。招股书显示，药捷安康是一家以临床需求为导向、处于注册临床阶段的生物制药公司，专注于发现及开发肿瘤、炎症及心脏代谢疾病小分子创新疗法。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"药捷安康-B上市一周累涨逾100%！核心产品替恩戈替尼获FDA快速通道认证","news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2546795228","title":"【港股异动 | 药捷安康-B(02617.HK)再涨超5% 总市值超110亿美元 恩戈替尼获美国FDA快速通道认证】智通","url":"https://stock-news.laohu8.com/highlight/detail?id=2546795228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546795228?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 14:13","pubTimestamp":1751004821,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617"],"gpt_icon":0},{"id":"2546019752","title":"【港股异动 | 药捷安康-B(02617.HK)尾盘拉升近5% 较招股价实现翻倍 替恩戈替尼获FDA快速通道认证】智通财","url":"https://stock-news.laohu8.com/highlight/detail?id=2546019752","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546019752?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 15:55","pubTimestamp":1750924523,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617"],"gpt_icon":0},{"id":"2545942223","title":"【港股异动 | 药捷安康-B(02617.HK)上市次日再涨6% 核心产品替恩戈替尼获FDA快速通道认证】智通财经APP","url":"https://stock-news.laohu8.com/highlight/detail?id=2545942223","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545942223?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 09:43","pubTimestamp":1750729422,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c0da6c4f23c253cde05681fde1ead024","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617"],"gpt_icon":0},{"id":"1141140888","title":"药捷安康-B续涨7%，总市值逼近100亿港元；该股昨日上市首日飙涨近79%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141140888","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141140888?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 09:41","pubTimestamp":1750729312,"startTime":"0","endTime":"0","summary":"6月24日，$药捷安康-B(02617)$续涨7%，总市值逼近100亿港元；该股昨日上市首日飙涨近79%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"03e355b77ba35e6757abcf8175791b1c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2545421720","title":"【药捷安康-B(02617.HK)：替恩戈替尼(TT-00420)被授予治疗MCRPC快速通道认证】智通财经APP讯，药","url":"https://stock-news.laohu8.com/highlight/detail?id=2545421720","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545421720?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 09:05","pubTimestamp":1750727155,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c0da6c4f23c253cde05681fde1ead024","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2552382132.HKD","00420","IE0004091025.USD","LU2764262908.HKD","BK1160","LU2552382058.USD","BK4533","LU0238689110.USD","LU0323239441.USD","LU0154245673.USD","BK4086","IE00B2PGVK34.USD","LU2720916845.USD","IE00BGHQF417.EUR","IE0004086264.USD","LU2764263203.CNY","SG9999002232.USD","LU2089279066.USD","BK4585","BK4504","LU2229751404.USD","IE00B3CCJ633.GBP","LU2764263039.SGD","LU2552382215.SGD","LU2211814178.USD","LU2211817866.USD","LU0154245756.USD","IE00BZ1G4Q59.USD","LU0323240290.USD","LU2463526074.USD","SG9999002224.SGD","02617","IE00BKVL7J92.USD","LU2133065610.SGD","TT","BK4588"],"gpt_icon":0},{"id":"2545299104","title":"【湾区早参】深圳二手房在售量超过72000套；广州发布智能网联汽车发展计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2545299104","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545299104?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 08:28","pubTimestamp":1750724898,"startTime":"0","endTime":"0","summary":"主要原因为：集团铝合金产品及氧化铝产品销售价格均较2024年同期上涨，销售数量亦有所增加。mCRPC为晚期前列腺癌的一种，属对去势治疗产生耐药并可能出现新转移的病症。此次于美的威灵量产的产品为该集团Gen3.0高压700V半桥氮化镓芯片产品。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1960965","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","BK1171","02577","02338","BK1500","BK1237","IE0034224299.USD","LU0173614495.USD","SG9999006597.SGD","BK1594","BK4081","LU1808992512.USD","SG9999001093.SGD","BK1592","LU0702159699.USD","BK1175","01497","01378","LU1166156734.SGD","LU0287142896.SGD","LU0737861699.HKD","LU1224709979.USD","BK1163","CCA","02533","BK4023","BK1522","SG9999014674.SGD","02617"],"gpt_icon":1},{"id":"2545423968","title":"药捷安康-B(02617.HK)：替恩戈替尼(TT-00420)被授予治疗MCRPC快速通道认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2545423968","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545423968?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 06:33","pubTimestamp":1750717990,"startTime":"0","endTime":"0","summary":"格隆汇6月24日丨药捷安康-B发布公告，美国食品药物管理局授予替恩戈替尼治疗转移性去势抵抗性前列腺癌患者的快速通道认证。mCRPC是导致前列腺癌患者死亡的主要因素。替恩戈替尼就治疗CCA获FDA授予孤儿药及快速通道认证，于中国获国家药品监督管理局突破性疗法认证，就治疗胆道癌获EMA孤儿药认证。替恩戈替尼是全球首个和唯一一个有潜力同时抑制FGFR/JAK通路，且针对mCRPC有临床疗效证据的研究药物。主要结果于2024年ASCO GU公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/24063351250120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4086","IE00B2PGVK34.USD","LU2720916845.USD","BK4504","LU2552382132.HKD","LU2764263203.CNY","LU2764262908.HKD","SG9999002232.USD","BK4533","BK4588","02617","IE00BZ1G4Q59.USD","LU0323239441.USD","LU2211817866.USD","LU0238689110.USD","00420","LU0154245673.USD","LU2552382058.USD","LU2133065610.SGD","SG9999002224.SGD","LU2089279066.USD","IE00BGHQF417.EUR","IE00B3CCJ633.GBP","IE0004091025.USD","LU2211814178.USD","IE00BKVL7J92.USD","IE0004086264.USD","LU2229751404.USD","LU2764263039.SGD","LU2463526074.USD","LU2552382215.SGD","LU0154245756.USD","BK4585","TT","BK1160","LU0323240290.USD"],"gpt_icon":1},{"id":"2545412373","title":"中信证券保荐生物科技领先公司药捷安康成功登陆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2545412373","media":"中信证券发布","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545412373?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 20:34","pubTimestamp":1750682096,"startTime":"0","endTime":"0","summary":"2025年6月23日，中信证券作为联席保荐人、联席整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人，助力药捷安康（南京）科技股份有限公司成功于港交所主板上市，发行规模约2.0亿港币。中信证券全球投资银行管理委员会联席主任程杰出席上市仪式。本项目是中信证券推动服务创新型生物医药行业的又一典型案例。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623204753a718d6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623204753a718d6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1147","BK1521","06030","LU1794554557.SGD","BK1564","02617","BK1516","LU1720050803.USD"],"gpt_icon":1},{"id":"2545498119","title":"【港股异动 | 康方生物(09926.HK)盘中涨近6% 药捷安康上市首日暴涨82% 康方生物为基石投资者之一】智通财经","url":"https://stock-news.laohu8.com/highlight/detail?id=2545498119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545498119?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 15:38","pubTimestamp":1750664281,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"03e355b77ba35e6757abcf8175791b1c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BPRC5H50.USD","LU1794554557.SGD","LU0348784397.USD","BK1161","BK1574","LU1720050803.USD","LU2488822045.USD","LU0417516571.SGD","02617","IE00B543WZ88.USD","09926","LU0348783233.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2545046731","title":"药捷安康登陆港交所 为今年南京江北新区首家上市企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2545046731","media":"e公司","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545046731?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 14:04","pubTimestamp":1750658640,"startTime":"0","endTime":"0","summary":"在公司负责人看来，诸多力量中，南京江北新区的支持是药捷安康顺利上市背后一支关键“助推剂”。药捷安康相关负责人说。“除了作为基石投资人投资药捷安康港股上市外，该只境外上市产业投资基金正在与新区另外几家计划境外上市企业对接。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623140543a4b850bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"03e355b77ba35e6757abcf8175791b1c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623140543a4b850bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617"],"gpt_icon":1},{"id":"2545466193","title":"港股午评：低开高走！三大指数盘中均转涨，半导体股拉升，港口及海运股大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2545466193","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545466193?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 12:00","pubTimestamp":1750651222,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"235bb3ef8fbd39f3e18c865168c85a4f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02343","MIUmain","09042","ALBmain","00700","DEFI","HSCEI","09439","EZBC","UNI.USD.HKCC","BITO","DOT.USD.HKCC","BTCO","APT.USD.HKCC","SNX.USD.HKCC","TON.USD.HKCC","03439","DOT.USD.CC","VBTC.AU","01024","AVAX.USD.CC","ATOM.USD.HKCC","APT.USD.CC","BTC.USD.HKCC","BTCW","00981","IBIT","HSTECH","LDO.USD.HKCC","BRRR","02609","01810","LINK.USD.HKCC","TCEHY","UNI.USD.CC","COMP.USD.CC","02050","DYDX.USD.HKCC","HSI","TON.USD.CC","SNX.USD.CC","USDT.USD.CC","COMP.USD.HKCC","MSTU","002050","MKR.USD.CC","03042","MCHmain","01347","02617"],"gpt_icon":0},{"id":"1184639598","title":"药捷安康-B上市首日盘中涨幅扩大至80%，中签一手赚超5000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184639598","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184639598?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 10:53","pubTimestamp":1750647238,"startTime":"0","endTime":"0","summary":"6月23日，$药捷安康-B(02617)$上市首日盘中涨幅扩大至80%，中签一手赚超5000港元，总市值超94亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2545946896","title":"“60后”博士四闯港交所，小分子Biotech开局大涨70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545946896","media":"动脉新医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545946896?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 10:03","pubTimestamp":1750644208,"startTime":"0","endTime":"0","summary":"2016年11月，吴永谦收购了药捷安康40%股权，并担任公司董事长。招股书显示，Tinengotinib是全球首个且唯一已进入注册临床阶段治疗FGFR抑制剂复发或难治性CCA患者的研究药物。在mCRPC领域，全球患者的五年生存率低于30%。直至截止日期2023年9月26日，350名实体瘤患者接受Tinengotinib单一疗法治疗，包括295名美国患者及55名中国患者。汇总安全性及耐受性数据显示，实体瘤患者对Tinengotinib耐受良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623101846a717e6a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623101846a717e6a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","HSTECH"],"gpt_icon":1},{"id":"1135221454","title":"异动解读 | 药捷安康-B上市首日大涨63%，创新药研发引爆投资热情","url":"https://stock-news.laohu8.com/highlight/detail?id=1135221454","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135221454?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:34","pubTimestamp":1750642469,"startTime":"0","endTime":"0","summary":"6月23日，生物制药公司药捷安康-B在港交所主板挂牌上市，股价表现亮眼。开盘即大涨63.12%，报21.45港元，展现出投资者对这家创新药企的强烈兴趣。药捷安康是一家专注于肿瘤、炎症及心脏代谢疾病小分子创新疗法的生物制药公司。此次IPO，药捷安康发行1528.1万股H股，每股发售价13.15港元，募集资金净额约1.61亿港元。药捷安康的成功上市不仅反映了投资者对生物医药行业的持续看好，也凸显了市场对具有创新能力和强大研发实力的企业的青睐。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":1},{"id":"1192489379","title":"异动解读 | 药捷安康-B上市首日大涨63%，IPO超额认购3420倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1192489379","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192489379?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:34","pubTimestamp":1750642447,"startTime":"0","endTime":"0","summary":"6月23日，生物制药公司药捷安康-B在港交所主板挂牌上市，股价表现强劲。盘中，该股大涨63.12%，引发市场广泛关注。药捷安康-B此次IPO反应热烈。公司公开发售部分获得约3420倍超额认购，显示投资者对其前景充满信心。作为一家专注于小分子创新药物开发的公司，药捷安康主要致力于肿瘤、炎症及心脏代谢疾病领域的治疗。投资者看好公司在生物制药领域的创新能力和市场潜力，推动其股价在上市首日大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":0},{"id":"2545145248","title":"港股早评：三大指数低开 科技金融走低 油气股、海运股大涨，三花智控首日上市低开7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545145248","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545145248?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:29","pubTimestamp":1750642171,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b295c95e8f71d6a2a7e969b359fae1eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159715","MPNGY","METmain","QMmain","BIDU","601995","HSImain","02050","01024","03086","HHImain","HSI","MHImain","00568","03690","02617","600026","USO","DUG","JD","SCO","YANG","HMTD.SI","09992","BZmain","NTES","02609","TTTN","TCHmain","09988","00700","HSTECH","01138","MCHmain","03908","UCO","TCEHY","KSTmain","02833","07226","BABA","CLmain","HSCEI","89618","ALBmain","159562","002050","09999","09618","002490"],"gpt_icon":0},{"id":"1133456971","title":"新股首日｜药捷安康-B飙涨超64%，佰泽医疗涨超24%，三花智控破发开跌7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133456971","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133456971?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:23","pubTimestamp":1750641828,"startTime":"0","endTime":"0","summary":"6月23日，港股三只新股正式挂牌港交所，药捷安康-B飙涨超64%，公开发售获逾3400倍认购；佰泽医疗涨超24%，公开发售获近26倍认购；三花智控跌超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","002050","LU2238339852.HKD","BK0197","159891","BK0028","02617","BK0187","LU2580892789.USD","02609","LU1969619763.USD","LU0359201612.USD","SGXZ49509284.SGD","LU1064130708.USD","BK0188","LU1023057109.AUD","LU0359202008.SGD","BK0076","BK0070","LU2580892862.HKD","LU1328615791.USD","LU2298064838.USD","02050"],"gpt_icon":0},{"id":"1136986243","title":"新股定价 | 药捷安康-B每股定价13.15港元，公开发售超购近3419倍，一手中签率0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136986243","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136986243?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 07:51","pubTimestamp":1750636291,"startTime":"0","endTime":"0","summary":" $药捷安康-B(02617)$ (02617.HK)公布招股结果，公司全球发售15,281,000股H股，每股H股13.15港元，所得款项净额1.6亿港元。香港公开发售接获3,419.87倍认购，一手(500股)中签率0.8%。国际发售录得0.97倍认购。经重新分配，公开发售股份已增加至305.7万股，占发售总数20%。股份预期今日(23日)挂牌。五名基石投资者江北医药、康方生物、华盛敦行、药石地平线及科瓴安合共认购1.3亿元公司股份。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/651cc17f66c60995aacb866f4503fece","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/651cc17f66c60995aacb866f4503fece"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"新股定价 | 药捷安康-B每股定价13.15港元，公开发售超购近3419倍，一手中签率0.8%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2545432833","title":"《新股》药捷安康(02617.HK)公开发售超购近3,419倍  一手中签仅0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545432833","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545432833?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 19:55","pubTimestamp":1750593300,"startTime":"0","endTime":"0","summary":"药捷安康－Ｂ(02617.HK)公布招股结果，香港公开发售接获3,419.87倍认购，一手(500股)中签率0.8%。国际发售录得0.97倍认购。经重新分配，公开发售股份已增加至305.7万股，占发售总数20%。股份预期周一(23日)挂牌。生物制药公司药捷安康是次全球发售1,528.1万股，公开发售占10%。招股价13.15元，集资净额1.61亿元。五名基石投资者江北医药、康方生物(09926.HK) 华盛敦行、药石地平线及科瓴安合共认购1.3亿元公司股份。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-06-20 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250613105253140_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250613105253140_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448313/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02617"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-06-26","current":-34.709071,"percent":0,"low":-34.709071,"twenty":-33.367742,"median":-31.953986,"eighty":-28.333869,"high":-17.403134,"avg":-29.633031,"sd":6.234327,"marketCap":10438407747},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-26","current":-34.709071,"twenty":-33.367742,"median":-31.953986,"eighty":-28.333869,"marketCap":10438407747}],"updateTime":1751006277901}}}